BIOTECHNOLOGY

Amgen reaches deal to use Bind’s technology to seek cancer drugs

BLOOMBERG FILE PHOTO
AMGEN INC. has reached a deal with Bind Biosciences to use Bind's nanotechnology to develop cancer drugs.
Posted 1/8/13

NEW YORK - Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences.

The two companies will share preclinical development of the drugs, which will target and block enzymes associated with cancer. The medicine was developed by Amgen, based in Thousand Oaks, Calif. It will be delivered using technology developed by Bind, based in Cambridge, Mass., and founded by Massachusetts Institute of Technology professor Robert Langer and Omid Farokhzad, an associate professor at Harvard Medical School.

The Bind technology is meant to selectively target the cancer cells, making it easier to deliver more potent doses of the drug there without poisoning healthy tissue. Once the particles locate the cancer tissue, they can release the Amgen drug. That may lead to fewer side-effects, according to Bind. Both companies will share the preclinical work, and Amgen will handle clinical development.

“Bind’s technology is well aligned with Amgen’s focus on the development of highly targeted and selective oncology therapeutics,” said Joseph P. Miletich, senior vice president of research and development at Amgen, in a statement. “We look forward to collaborating with the Bind scientific team to leverage this technology to address unmet medical needs of cancer patients.”

Bind will receive upfront and development milestone payments of $46.5 million, with an additional $134 million for regulatory and sales milestones. If the product is commercialized, Bind will receive royalties.

Calendar
PBN Hosted
Events

Two Great Programs...One Great Event. PBN's Annual Celebration of Growth and Innovation is now underway. 2014 applications are now available. Deadline August 1st.
  • Healthiest Employers
    Celebrate with the Healthiest Employers in RI on August 14th at the Providence M ...
  • 40 Under Forty
    Thank you to our sponsors and to all those who attended the 10th Anniversary of ...
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News
    Advertisement